Electrochemical Evaluation of LaNi_(5–x)Ge_x Metal Hydride Alloys

We report a detailed evaluation of Ge-substituted LaNi_5 for electrochemical application as a negative electrode in alkaline rechargeable cells. Alloys with small substitutions of Ge for Ni show operating pressures, chargeability, cyclic lifetime, and kinetics for hydrogen absorption and desorption all superior to those found in many other substituted LaNi_5 alloys. These improved properties were achieved with a minimal reduction in hydrogen storage capacity

Electrochemical Studies on LaNi5–xSnx Metal Hydride Alloys

Electrochemical studies were performed on LaNi5–xSnx with 0 <= x <= 0.5. We measured the effect of the Sn substituent on the kinetics of charge-transfer and diffusion during hydrogen absorption and desorption, and the cyclic lifetimes of LaNi5–-xSnx electrodes in 250 mAh laboratory test cells. We report beneficial effects of making small substitutions of Sn for Ni in LaNi5 on the performance of the metal hydride alloy anode in terms of cyclic lifetime, capacity, and kinetics. The optimal concentration of Sn in LaNi5–xSnx alloys for negative electrodes in alkaline rechargeable secondary cells was found to lie in the range 0.25 <= x <= 0.3

Electrochemical Properties of LaNi5–xGex Alloys in Ni-MH Batteries

Electrochemical studies were performed on LaNi5–xGex metal hydride alloys with 0 <= x <= 0.5. We carried out single-electrode studies to understand the effects of the Ge substituent on the hydrogen absorption characteristics, the electrochemical capacity, and the electrochemical kinetics of hydrogen absorption and desorption. The electrochemical characteristics of the Ge-substituted alloys are compared to those of the Sn-substituted alloys reported earlier. LaNi5–xGex alloys show compositional trends similar to LaNi5–xSnx alloys, but unlike the Sn-substituted alloys, Ge-substituted alloys continue to exhibit facile kinetics for hydrogen absorption/desorption at high solute concentrations. Cycle lives of LaNi5–xGex electrodes were measured in 300 mAh laboratory test cells and were found to be superior to the Sn-substituted LaNi5 and comparable to a Mm(Ni,Co,Mn,Al)5 alloy. The optimum Ge content for LaNi5–xGex metal hydride alloys in alkaline rechargeable cells is in the range 0.4 <= x <= 0.5

Hydrogen desorption and adsorption measurements on graphite nanofibers

Graphite nanofibers were synthesized and their hydrogen desorption and adsorption properties are reported for 77 and 300 K. Catalysts were made by several different methods including chemical routes, mechanical alloying, and gas condensation. The nanofibers were grown by passing ethylene and H2 gases over the catalysts at 600 °C. Hydrogen desorption and adsorption were measured using a volumetric analysis Sieverts' apparatus, and the graphite nanofibers were characterized by transmission electron microscopy and Brunauer–Emmett–Teller surface area analysis. The absolute level of hydrogen desorption measured from these materials was typically less than the 0.01 H/C atom, comparable to other forms of carbon

Hydrogen adsorption and cohesive energy of single-walled carbon nanotubes

Hydrogen adsorption on crystalline ropes of carbon single-walled nanotubes (SWNT) was found to exceed 8 wt.%, which is the highest capacity of any carbon material. Hydrogen is first adsorbed on the outer surfaces of the crystalline ropes. At pressures higher than about 40 bar at 80 K, however, a phase transition occurs where there is a separation of the individual SWNTs, and hydrogen is physisorbed on their exposed surfaces. The pressure of this phase transition provides a tube-tube cohesive energy for much of the material of 5 meV/C atom. This small cohesive energy is affected strongly by the quality of crystalline order in the ropes

Rising to the challenge of defining and operationalising multimorbidity in a UK hospital setting: the ADMISSION research collaborative

\ua9 The Author(s) 2024. Purpose: Greater transparency and consistency when defining multimorbidity in different settings is needed. We aimed to: (1) adapt published principles that can guide the selection of long-term conditions for inclusion in research studies of multimorbidity in hospitals; (2) apply these principles and identify a list of long-term conditions; (3) operationalise this list by mapping it to International Classification of Diseases 10th revision (ICD-10) codes. Methods: Review by independent assessors and ratification by an interdisciplinary programme management group. Results: Agreement was reached that when defining multimorbidity in hospitals for research purposes all conditions must meet the following four criteria: (1) medical diagnosis; (2) typically present for ≥ 12 months; (3) at least one of currently active; permanent in effect; requiring current treatment, care or therapy; requiring surveillance; remitting-relapsing and requiring ongoing treatment or care, and; (4) lead to at least one of: significantly increased risk of death; significantly reduced quality of life; frailty or physical disability; significantly worsened mental health; significantly increased treatment burden (indicated by an increased risk of hospital admission or increased length of hospital stay). Application of these principles to two existing lists of conditions led to the selection of 60 conditions that can be used when defining multimorbidity for research focused on hospitalised patients. ICD-10 codes were identified for each of these conditions to ensure consistency in their operationalisation. Conclusions: This work contributes to achieving the goal of greater transparency and consistency in the approach to the study of multimorbidity, with a specific focus on the UK hospital setting